Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VeradigmSTU:AL21 17 Days Payable is 21.46 as of Dec. 2022. GuruFocus rates STU:AL21 with a GF Score™ of 17/100. Among 607 Healthcare Providers & Services companies, Veradigm ranks worse than 164744.48% on this metric.
Veradigm's average Accounts Payable for the
six
months ended in Dec. 2022 was €15.5 Mil. Veradigm's Cost of Goods Sold for the
six
months ended in Dec. 2022 was €263.9 Mil.
Hence, Veradigm's Days Payable for the
six
months ended in Dec. 2022 was 10.73.
The historical rank and industry rank for Veradigm's Days Payable or its related term are showing as below:
STU:AL21's Days Payable is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 57.13 * Ranked among companies with meaningful Days Payable only.
Veradigm's Days Payable
declined
from Dec. 2020 (92.84) to Dec. 2022 (21.46).
It may suggest that Veradigmaccelerated paying its suppliers.
Veradigm Days Payable Related Terms
Veradigm Days Payable Historical Data
* Premium members only.
The historical data trend for Veradigm's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:AL21 vs CTEV, EVH, PHR: Days Payable Comparison
For the Health Information Services subindustry, Veradigm's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veradigm Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veradigm's Days Payable distribution charts can be found below:
* The bar in red indicates where Veradigm's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Veradigm's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veradigm (STU:AL21) has a Days Payable of 21.46 as of Dec. 2022. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Veradigm and its competitors. According to the industry distribution chart, Veradigm ranks #999999 out of 607 companies in the Healthcare Providers & Services industry.
Is Veradigm's Days Payable too high?
Veradigm's current Days Payable is 21.46. The Healthcare Providers & Services industry median Days Payable is 57.13. Veradigm's value of 21.46 is 62.4% below this industry median. Based on the distribution chart, Veradigm ranks #999999 out of 607 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Veradigm has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Veradigm's Days Payable compare to CTEV and EVH?
According to the Healthcare Providers & Services industry distribution chart, Veradigm ranks #999999 out of 607 companies for Days Payable. This places Veradigm in the lower half of its industry. The industry median Days Payable is 57.13. Veradigm's value of 21.46 is 62.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.13, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veradigm's current Days Payable of 21.46 is 62.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Veradigm and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veradigm's current Days Payable is 21.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veradigm stock overvalued right now?
Veradigm (STU:AL21) has a current Days Payable of 21.46. The current Days Payable is 21.46 and 62.4% below the Healthcare Providers & Services industry median of 57.13. Veradigm's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Veradigm (STU:AL21), the current Days Payable is 21.46 as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Veradigm Inc together with its subsidiaries, is a healthcare software-as-a-service (SaaS) technology, data and analytics company spanning the three pillars of healthcare: Provider, Payer and Life Science. Its Provider segment represents the source of revenue, followed by the Payer segment, with the Life Science segment contributing a comparatively smaller portion. Its portfolio addresses a range of healthcare industry needs, with the goal of transforming health insightfully, providing key healthcare stakeholders with data, insights and artificial intelligence (AI) enhanced solutions to help improve health outcomes and reduce costs.
17GF Score
Get the complete analysis for STU:AL21
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:AL21 has been successfully added to your 
